Clinical trial
A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and…
NCT00253110 · Janssen, LP, Industry · Completed
Key facts
| NCT number | NCT00253110 |
|---|---|
| Title | A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder |
| Official title | A Comparison of Risperidone and Haloperidol for Prevention of Relapse in Subjects With Schizophrenia and Schizoaffective Disorders |
| Lead sponsor | Janssen, LP, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder |
| Intervention type | Drug |
| Interventions | risperidone, haloperidol |
| Enrollment | 396 |
| Start date | May 1, 1996 |
| Completion | Sep 1, 1998 |
| First posted | Nov 15, 2005 |
| Last update posted | Aug 6, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: